Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2003
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003051328A1 Solid dose micro implant
06/26/2003WO2003051277A2 Novel compounds
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003051180A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
06/26/2003WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
06/26/2003US20030120079 Such as 7-((R)-2-((E)-3-(3-Benzyl-phenyl)-3-hydroxy-propenyl)-5-oxo-pyrrolidin-1-yl)-heptanoic acid; side effects reduction
06/26/2003US20030120074 Cardioprotective phosphonates and malonates
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030120045 Immobilization onto polyoxyethylene glycol
06/26/2003US20030119882 Solid pharmaceutical composition containing torasemide
06/26/2003US20030119877 Pyridine derivatives useful as cyclooxygenase inhibitor
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119822 Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119787 Phosphonic acid derivative having inhibitory activity against carboxypeptidase B
06/26/2003US20030119742 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587,10183, 10550, 12680, 17921, 32248, 60489 or 93804
06/26/2003US20030119728 Stable, nasally, orally or sublingually applicable pharmaceutical preparation
06/26/2003US20030119727 FVIIa antagonists
06/26/2003US20030119148 Amino-terminally truncated rantes as chemokine antagonists
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119036 Isolated nucleic acids; anticholesterol agents, cardiovascular disorders, antiinflammatory agents, antilipemic agents
06/26/2003US20030118666 Injectable solution containing a shark-derived chondroitin sulfate iron colloid
06/26/2003US20030118644 A solid forms comprising low molecular weight peptide-based thrombin inhibitor having pH dependent solubility, cellulose or starch as disintegrant fillers; immediate release
06/26/2003US20030118584 Administration of antibody combining site-containing molecules that specifically bind to specific class of reversibly-bound GPIIb/IIIa fibrinogen receptor antagonist compounds
06/26/2003US20030118582 Pharmaceutical composition comprising factor VII polypeptides and protein C inhibitors
06/26/2003US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470811A1 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
06/26/2003CA2470479A1 Polymorphs of clopidogrel hydrogensulfate
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2469984A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
06/26/2003CA2469950A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003CA2469786A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
06/26/2003CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
06/26/2003CA2469048A1 Quinolinones as prostaglandin receptor ligands
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320536A1 $g(a)-SUBSTITUTED $g(b)-AMINOETHYL PHOSPHONATES
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1320521A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents
06/25/2003EP1320371A2 Charged phospholipid compositions and methods for their use
06/25/2003EP1320368A1 Infusion of ciprofloxacin having reduced acid content and being stable in storage
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1140019B1 Aerosol formulations for buccal and pulmonary application
06/25/2003EP1025086B1 Benzamidine derivatives as factor xa inhibitors
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003EP0641343B1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426407A N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426311A Medicament for stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and method for production thereof
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1426301A Compositions for treatment and prevention of cardiovascular diseases
06/25/2003CN1426296A Hemostat agent, method and carrier for applying blood clotting agent
06/25/2003CN1425461A Injection preparation for resisting platelet aggregation and its producing method
06/25/2003CN1425448A Medicine for curing thrombotic phlebitis
06/25/2003CN1425442A Wound fast heeling medicine
06/25/2003CN1425412A Compound oral thrombolytic preparation and its preparing method
06/25/2003CN1425391A Thrombolytic leech capsule and its preparing method
06/25/2003CN1425375A Ligustrazine hydrochloride freeze-dried preparation for injection and its preparing method
06/25/2003CN1112363C Bicyclic pyrimidine derivatives and their use as anti-coagulants
06/25/2003CN1112198C Use of Yexiazhu and its plant alcohol extract in pharmaceutical production
06/25/2003CN1112196C Medicine for regulating blood fat and reducing plasma fibrin
06/25/2003CN1112192C Exterior-applied medicine for treating scald and its preparing method
06/25/2003CN1112190C Powdered medicine for treating internal hemorrhage
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583272 Protein conjugate for use in the treatment of blood disorders
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583173 Useful as anticoagulants in mammals; inhibitors of factor Xa
06/24/2003US6583145 Thio-oxindole derivatives
06/24/2003US6583134 Aza- indolyl derivatives for treating obesity
06/24/2003US6583108 Human bikunin
06/24/2003US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids
06/19/2003WO2003050504A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
06/19/2003WO2003050252A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
06/19/2003WO2003050251A2 Hematopoietic cells from human embryonic stem cells
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050088A1 Substituted heterocyclic carboxamides with antithrombotic activity
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003049784A2 Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
06/19/2003WO2003049754A1 The use of osteogenic growth peptide in the enhancement of haemopoiesis
06/19/2003WO2003049742A1 Method for administering birb 796 bs
1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 671